Volatile Week, but Green? Click to watch the new Podcast.

$12.00 (10.29%)

Volume: 634.321k

Closed: Jul 05, 2022

Hollow Logo Score: 3.149

Codexis Stock Forecast

$12.00 (10.29%)

Volume: 634.321k

Closed: Jul 05, 2022

Score Hollow Logo 3.149

Codexis Company Profile

200 Penobscot Drive

Redwood City CA 94063



Industry: Biotechnology

Sector: Healthcare



Codexis, Inc. develops biocatalysts for the pharmaceutical and fine chemicals markets in the United States, Europe, Asia, and internationally. The company provides Codex biocatalyst panels and kits to customers that are engaged in drug development and drug manufacturing to allow them to screen and identify possible enzymes that can be applied in the manufacturing processes for their drug candidates and their marketed products. It also offers enzyme screening services and enzyme optimization services; and supplies enzymes, pharmaceutical intermediates, and active pharmaceutical ingredients. In addition, it develops biocatalysts for use in the fine chemicals market, including food and food ingredients, animal feed, flavors and fragrances, and agricultural chemicals. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE